3654 results for «460»

Filter By

3654 results

Drug-eluting balloon in calcified lesions and complex lesions

28 Feb 2026 – From Euro4C Annual Meeting 2026

This session explores the application of drug-eluting balloons (DCB) in managing calcified and complex coronary lesions. Emphasis is placed on identifying appropriate lesions for a DCB-only strategy, the critical role of vessel preparation prior to drug delivery, and the long-term physiological assessment following treatment, supported by...

Drug-eluting balloon in calcified lesions and complex lesions

The best cases of the Euro4C PCRonline website

28 Feb 2026 – From Euro4C Annual Meeting 2026

This session presents some of the most instructive and challenging cases featured on the Euro4C PCRonline website. The cases encompass management of stalled rotational atherectomy burrs, combined use of intravascular lithotripsy and Impella in saphenous vein grafts, complexities of calcium in tortuous anatomy, and strategies for...

The best cases of the Euro4C PCRonline website

ResilCard - A resilience assessment tool to ensure cardiovascular care continuity during crises

28 Feb 2026 – From Euro4C Annual Meeting 2026

Introducing ResilCard, a novel resilience assessment tool designed to maintain continuity of cardiovascular care during crises. This session highlights the importance of preparedness and adaptive strategies to ensure uninterrupted patient management in challenging healthcare environments.

ResilCard - A resilience assessment tool to ensure cardiovascular care continuity during crises

Closing Ceremony

28 Feb 2026 – From Euro4C Annual Meeting 2026

The closing ceremony marks the conclusion of the conference, providing a summary of key learnings, acknowledgments, and final reflections on the advancements and discussions presented throughout the event.

Euro4C Annual Meeting 2026 Closing Ceremony

Late-breaking trials of PCR Tokyo Valves 2026

14 Feb 2026 – From PCR Tokyo Valves 2026

This session presents pivotal late-breaking trials from PCR Tokyo Valves 2026, offering one-year outcomes and real-world experiences in transcatheter valve therapies. Highlights include the AltaValve early feasibility study on atrial fixation TMVR, invasive registry insights on prosthesis-patient mismatch post-TAVR, and registry data on tricuspid and mitral...

Late-breaking trials of PCR Tokyo Valves 2026

Procedural imaging for tricuspid valve interventions

15 Feb 2026 – From PCR Tokyo Valves 2026

Dedicated to procedural imaging for tricuspid valve interventions, this session elucidates anatomical and pathophysiological features critical for successful transcatheter procedures. It emphasizes technical aspects of TEE and ICE imaging, including 3D multiplanar reconstruction, and offers case-based learning to refine imaging skills and optimize procedural outcomes.

Procedural imaging for tricuspid valve interventions

Prevention and management of TAVI complications

14 Feb 2026 – From PCR Tokyo Valves 2026

This session addresses the prevention and management of major complications associated with transcatheter aortic valve implantation (TAVI). Attendees will gain a detailed understanding of mechanisms behind cerebral infarction, haemolysis, valve infolding, pacemaker implantation, and valve migration, along with expert strategies for recognition, decision-making, and bailout techniques...

Prevention and management of TAVI complications

Main vessel stenting in DK-Crush: lessons from stepwise provisional strategy

  • Optimisation of side branch stenting
  • How to optimally deploy the second stent

Commented by Goran Stankovic and William Wijns

Part 3 of a 3-part series. Previous episode: How to correct incomplete crush and how to prevent lack of carina coverage

Main vessel stenting in DK-Crush: lessons from stepwise provisional strategy

Transcatheter management of failed THV - LIVE case

09 Feb 2025 – From PCR Tokyo Valves 2025

An 84-year-old woman with diabetes mellitus, frailty (5/6), preserved LV function, and aortic stenosis previously treated with CoreValve 26 mm in 2016, presented with symptomatic degenerative stenosis of the valve.
A Sapien 3 (23 mm) was implanted without predilatation but with post-dilatation under general anaesthesia, using cerebral...

Transcatheter management of failed THV - LIVE case

Coronary access and revascularisation in patients undergoing TAVI: from work-up to lifetime management

15 Feb 2026 – From PCR Tokyo Valves 2026

This session delves into the comprehensive management of ischemic heart disease in patients undergoing transcatheter aortic valve implantation (TAVI). It highlights the critical importance of maintaining coronary access post-TAVI and explores how various valve designs affect coronary accessibility, particularly in cases involving valve-in-valve (TAV-in-TAV) procedures, guiding...

Coronary access and revascularisation in patients undergoing TAVI: from work-up to lifetime management

Transcatheter options for degenerated surgical aortic valves - LIVE case

08 Feb 2025 – From PCR Tokyo Valves 2025

A 77-year-old male with a history of SAVR in 2011 (Magna Ease 23) and moderate chronic kidney disease, with preservedLV function, presented with symptomatic severe aortic regurgitation and stenosis, associated with severe MR.

A Sapien 3 Ultra Resilia 23 valve was implanted under local anesthesia, with hemodynamic...

Transcatheter options for degenerated surgical aortic valves - LIVE case

TOMAHAWK: immediate angiography after out-of-hospital cardiac arrest without ST-segment elevation

29 Aug 2021

Elad Asher analyses this study which compared the benefits of immediate coronary angiography with those of initial intensive care assessment with delayed angiography after out-of-hospital cardiac arrest. Hot Line session of the ESC Congress 2021.

Elad Asher

Author

Elad Asher
TOMAHAWK: immediate angiography after out-of-hospital cardiac arrest without ST-segment elevation

FRACTURE IDE trial of the Boston Scientific SEISMIQ™ 4CE coronary intravascular lithotripsy catheter meets primary safety and effectiveness endpoints

18 May 2026

ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation

31 Aug 2021

Following the Hot Line session of the ESC Congress 2021 presented by George Dangas (New-York, USA), Daniele Giacoppo offers us a condensed version of this study.

Daniele Giacoppo

Author

Daniele Giacoppo
ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation
Didn’t find what you were looking for?